Patents by Inventor Mathieu Lupien

Mathieu Lupien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220284983
    Abstract: The present disclosure relates to the development of methods for identifying cis-regulatory elements. Also disclosed herein are various methods including for example determining the tissue of origin of a biological sample, prognosis of a patient diagnosed with a cancer and their response to treatments.
    Type: Application
    Filed: August 3, 2020
    Publication date: September 8, 2022
    Inventors: Mathieu Lupien, Benjamin Haibe-Kains, Seyed Ali Madani Tonekaboni
  • Patent number: 9382588
    Abstract: The present invention includes methods for identifying patients who will be resistant to endocrine therapy during breast cancer treatment and determining patient outcome. The methods are based on identifying increased expression of PBX1, or the cistrome signature associated therewith, in breast tissue samples.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: July 5, 2016
    Assignee: Trustees of Dartmouth College
    Inventors: Mathieu Lupien, Luca Magnani
  • Publication number: 20140011695
    Abstract: The present invention includes methods for identifying patients who will be resistant to endocrine therapy during breast cancer treatment and determining patient outcome. The methods are based on identifying increased expression of PBX1, or the cistrome signature associated therewith, in breast tissue samples.
    Type: Application
    Filed: February 15, 2012
    Publication date: January 9, 2014
    Applicant: TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Mathieu Lupien, Luca Magnani